Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BldD is a transcription factor found in *Streptomyces coelicolor* and related actinomycetes, acting as a global regulator essential for both morphological development (including formation of aerial hyphae and sporulation) and production of secondary metabolites such as antibiotics[2][3][4][5][6][7][11]. BldD functions as a DNA-binding homodimer with a characteristic helix-turn-helix motif that binds specific inverted repeat sequences in the promoter regions of its target genes[3][4][9]. The BldD regulon comprises over 160 genes, many encoding other regulatory proteins, enzymes, and factors involved in differentiation and metabolism[2]. BldD represses target gene expression during vegetative growth, preventing premature developmental transitions[5][7]. Deletion or mutation of bldD leads to dramatic defects in differentiation and secondary metabolism, highlighting its central, pleiotropic regulatory role[2][3][5]. While BldD is not classified as a therapeutic target for drugs, it is crucial for understanding bacterial development, antibiotic biosynthesis, and could be indirectly important for optimizing antibiotic production in industrial microbiology[4][6][12][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BldD transcription factor (BldD).